InvestorsHub Logo
Followers 45
Posts 5213
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Friday, 04/26/2024 11:17:06 AM

Friday, April 26, 2024 11:17:06 AM

Post# of 462168
“Increased statistical power of EEG/ERP biomarkers to help minimize trial size and cost • Streamlined regulatory process for trials leveraging the EEG/ERP biomarkers”

https://erpbiomarkers.org/

Seems to me this kind of consortium would help call the bluff of a company trying to stretch out its so called failures. Spending 2+ years in a co sortium figuring out specific disease characteristics and measuring metrics is advancing medicine not delaying. All this bei g said Im beginning to believe the Schizophrenia trial could advance to a new stage rather quickly with these new qualifying biomarker tools.

This company is a complete fraud or a grand slam, cant be both or any where in the middle imo and partnerships like this only add to the strength and integrity if you ask me. This is leading, not following the herd off the cliff thinking. Im sure all companies involved are keeping a close eye on trial design and results of our Schizophrenia trial. Our trials keep getting stronger and stronger with time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News